推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Current Molecular Pharmacology 期刊收藏夹

2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   IF范围: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

  
AI写作痕迹消减工具

 
近期推荐：
热
全流程投稿协助套餐服务
热
SCI论文AI润色+人工QC服务
热
Springer Nature特刊征稿
新
已发表SCI？是时候来Springer出书了！

按研究方向查看：


Current Molecular Pharmacology期刊基本信息Hello，您是该期刊的第26718位访客

基本信息 登录收藏
期刊名字Current Molecular PharmacologyCurrent Molecular Pharmacology

CURR MOL PHARMACOL
（此期刊被最新的JCR期刊SCIE收录）

LetPub评分
6.5
56人评分
我要评分

声誉
7.8

影响力
5.3

速度
7.3

期刊ISSN1874-4672
安装APP，查看期刊最新消息
iOS版下载安装安卓版下载安装
E-ISSN1874-4702
2025-2026最新IF
（数据来源于网友提供）		注册或登录后，查看IF
实时影响因子 截止2026年5月06日：7.11
2025-2026自引率0.0%点击查看自引率趋势图
五年IF
（数据来源于网友提供）		4.996数据由网友[沉默星星]收集提供
h-index 34
CiteScore
（ 2026年6月最新版）
CiteScoreSJRSNIPCiteScore排名
7.801.0240.919
学科分区排名百分位
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Pharmacology		Q166 / 328
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Drug Discovery		Q137 / 161
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Molecular Medicine		Q251 / 179

期刊简介
Current Molecular Pharmacology aims to publish the latest developments in cellular and molecular pharmacology with a major emphasis on the mechanism of action of novel drugs under development, innovative pharmacological technologies, cell signaling, transduction pathway analysis, genomics, proteomics, and metabonomics applications to drug action. An additional focus will be the way in which normal biological function is illuminated by knowledge of the action of drugs at the cellular and molecular level. The journal publishes full-length/mini reviews, original research articles and thematic issues on molecular pharmacology.

Current Molecular Pharmacology is an essential journal for every scientist who is involved in drug design and discovery, target identification, target validation, preclinical and clinical development of drugs therapeutically useful in human disease.
期刊官方网站https://www.sciencedirect.com/journal/current-molecular-pharmacology
期刊投稿格式模板
VIP专享
Word版格式模板  
此模板由LetPub整理，仅供参考。开通VIP可免费下载，并享1w+期刊模板资源。
 
期刊投稿网址https://www.editorialmanager.com/cmp/default2.aspx
作者指南网址https://www.sciencedirect.com/journal/current-molecular-pharmacology/publish/guide-for-authors
该期刊中国学者近期发文 - NewOncology drug resistance prediction tools: Database infrastructure, algorithmic innovation, and clinical translation
Author: Wang, Jia; Zhu, Hong-Rui; Xu, Jing; Fu, Jie; Liu, Li-Yun; Chen, Xuan-Yu; Chen, Zhe-Sheng; Zhou, Hai-Yan; Liu, Zhe; Lin, Hou-Wen; Gu, Zhi-Chun
Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 85-96. DOI: 10.1016/j.cmp.2026.04.001

Integrative transcriptomic and metabolomic analyses of puerarin against cholestatic liver fibrosis
Author: Zhu, Danhua; Shi, Qingmiao; Ouyang, Xiaoxi; Zhang, Yanhong; Yu, Xiaopeng; Yang, Long; Su, Kunkai; Li, Lanjuan
Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 112-121. DOI: 10.1016/j.cmp.2026.04.003

Metabolic reprogramming and epigenetic regulation: The dual role of lactate and lactylation in pancreatic ductal adenocarcinoma progression and therapeutics
Author: Li, Xiang; Guo, Wei; Xie, Yihan; Li, Ryan; Li, Wenxin; Wang, Han; Du, Ruixia; Jiang, Hong; Liu, Yefu; Liu, Zhe
Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 97-111. DOI: 10.1016/j.cmp.2026.04.002

Lactobacillus rhamnosus CMU-pb-7 alleviates diabetic nephropathy in a high-fat diet-streptozotocin rat model
Author: Jiang, Jie; Zhang, Yuancheng; Zheng, Cizhen; Zhang, Shaobing; Ding, Yali; Liang, Yanfang; Huang, Juan; Chai, Xingxing; Lin, Bihua; Sun, Jiahui; Ye, Ziyu; Wei, Biaowen; Wang, Shaobo; Yang, Qunfeng; Zeng, Jincheng
Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 122-132. DOI: 10.1016/j.cmp.2026.03.005

期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Current Molecular Pharmacology的语言要求，还能让Current Molecular Pharmacology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Current Molecular Pharmacology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿
是否OA开放访问Yes
通讯方式16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING, Peoples R China, DONGCHENG DISTRICT, 100009
出版商KEAI PUBLISHING LTD
涉及的研究方向Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
出版国家或地区United Arab Emirates
出版语言English
出版周期
出版年份0
年文章数 25点击查看年文章数趋势图
Gold OA文章占比58.16%
研究类文章占比：
文章 ÷（文章 + 综述）		72.00%
期刊分区表预警名单 2026年03月发布的新锐学术版：不在预警名单中

2025年03月发布的2025版：不在预警名单中

2024年02月发布的2024版：不在预警名单中

2023年01月发布的2023版：不在预警名单中

2021年12月发布的2021版：不在预警名单中

2020年12月发布的2020版：不在预警名单中
《新锐期刊分区表》
（ 2026年3月发布） 		点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
生物学 2区2区2区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学		3区2区3区
PHARMACOLOGY & PHARMACY
药学		1区3区3区
否N/A
期刊分区表
（ 2025年3月升级版）
大类学科小类学科Top期刊综述期刊
生物学 2区4区4区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学		3区3区4区
PHARMACOLOGY & PHARMACY
药学		1区3区4区
否否
期刊分区表
（ 2023年12月旧的升级版）
大类学科小类学科Top期刊综述期刊
生物学 1区4区3区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学		4区1区4区
PHARMACOLOGY & PHARMACY
药学		2区1区4区
否否
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1874-4672%5BISSN%5D
平均审稿速度网友分享经验：

平均录用比例网友分享经验：
APC文章处理费信息
版面费：Authors are required to pay an Article Publishing Charge (APC) of 2500 US dollars to cover the expenses associated with the publication process.
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Current Molecular Pharmacology顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。
提交文稿
期刊常用信息链接
同领域相关期刊 Current Molecular Pharmacology期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Current Molecular Pharmacology期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Current Molecular Pharmacology上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Journal of Applied Research on Medicinal and Aromatic Plants07.40
    Current Enzyme Inhibition01.50
    Drug Discovery Today: Technologies015.80
    Journal of HerbMed Pharmacology03.00
    Open Access Journal of Medicinal and Aromatic Plants00.00
    International Journal of Computational Biology and Drug Design00.60
    Drug Discovery Today: Disease Models02.60
    Current Drug Discovery Technologies02.90
    期刊分区表同大类学科的热搜期刊 浏览次数
    International Journal of Biological Macromolecules1990780
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES1679890
    Frontiers in Plant Science983103
    Frontiers in Microbiology961174
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS678611
    PeerJ589596
    Cell Reports570440
    BMC GENOMICS557513
    Cell Death & Disease548178
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY508413
  •  

    Current Molecular Pharmacology Current Molecular Pharmacology
    我来预测明年：
    稳步上升 表现平稳 逐渐下降　 刷新
  •  

    		  
  •  

    		  
  •  

    		  
  • 中国学者近期发表的论文
    1.Oncology drug resistance prediction tools: Database infrastructure, algorithmic innovation, and clinical translation

    Author: Wang, Jia; Zhu, Hong-Rui; Xu, Jing; Fu, Jie; Liu, Li-Yun; Chen, Xuan-Yu; Chen, Zhe-Sheng; Zhou, Hai-Yan; Liu, Zhe; Lin, Hou-Wen; Gu, Zhi-Chun
    Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 85-96. DOI: 10.1016/j.cmp.2026.04.001        DOI
    2.Integrative transcriptomic and metabolomic analyses of puerarin against cholestatic liver fibrosis

    Author: Zhu, Danhua; Shi, Qingmiao; Ouyang, Xiaoxi; Zhang, Yanhong; Yu, Xiaopeng; Yang, Long; Su, Kunkai; Li, Lanjuan
    Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 112-121. DOI: 10.1016/j.cmp.2026.04.003        DOI
    3.Metabolic reprogramming and epigenetic regulation: The dual role of lactate and lactylation in pancreatic ductal adenocarcinoma progression and therapeutics

    Author: Li, Xiang; Guo, Wei; Xie, Yihan; Li, Ryan; Li, Wenxin; Wang, Han; Du, Ruixia; Jiang, Hong; Liu, Yefu; Liu, Zhe
    Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 97-111. DOI: 10.1016/j.cmp.2026.04.002        DOI
    4.Lactobacillus rhamnosus CMU-pb-7 alleviates diabetic nephropathy in a high-fat diet-streptozotocin rat model

    Author: Jiang, Jie; Zhang, Yuancheng; Zheng, Cizhen; Zhang, Shaobing; Ding, Yali; Liang, Yanfang; Huang, Juan; Chai, Xingxing; Lin, Bihua; Sun, Jiahui; Ye, Ziyu; Wei, Biaowen; Wang, Shaobo; Yang, Qunfeng; Zeng, Jincheng
    Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 122-132. DOI: 10.1016/j.cmp.2026.03.005        DOI
    5.PVT1&EIF4A1 promote metastasis through regulating Notch-1 signaling pathway via STC-1 in gastric cancer

    Author: Cao, Dongdong; Yang, Rui; Zhang, Lei; Zhou, Xuan; Zhong, Min; Pan, Zemin; Zhou, Naiming; Li, Fangling; Li, Dongmei
    Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 74-84. DOI: 10.1016/j.cmp.2026.02.003        DOI
    6.Targeting fPRDM16 to restore collagen phagocytosis: A mechanism to counteract the persistent fibrosis in aging lungs

    Author: Peng, Jun; Zhang, Yue; Huang, Wenhui; Wang, Wei; Zeng, Wenyi; Li, Wenhan; Xiao, Linjie; Meng, Ying
    Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 61-73. DOI: 10.1016/j.cmp.2026.02.002        DOI
    7.Gramine suppresses triple-negative breast cancer by inducing ferroptosis via CUL3-mediated ubiquitination of MTDH

    Author: Zhou, Shangjun; Zhu, Xudong; Xu, Zhijie; Yi, Qiaoli; Wang, Jiayu; Wang, Xia; Zhang, Kejing; Yu, Keda; Yan, Yuanliang
    Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 14-26. DOI: 10.1016/j.cmp.2026.03.001        DOI
    8.The mechanism of lactylation modification in the progression and drug resistance of lung cancer: A review

    Author: Yi, Jiaoyu; Tao, Bo; Chen, Hao; Horita, Nobuyuki; Xu, Yong
    Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 27-40. DOI: 10.1016/j.cmp.2026.03.004        DOI
    9.IGFBP1 is a potential monitoring biomarker of disease activity in elderly patients with inflammatory bowel disease

    Author: Yang, Shuting; Jiang, Tingwang; Shi, Zhiliang; Zhou, Fang; Yu, Hongshuang; Huang, Jiefang; Li, Xuefeng; Guo, Jian; Zhao, Hongmei; Zhang, Qi; Wang, Bei; Zhou, Jieru; Zhang, Yanyun; Zhou, Guoqiang
    Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 1-13. DOI: 10.1016/j.cmp.2026.02.001        DOI
    10.Stimulation of Soluble Guanylyl Cyclase (sGC) by Cinaciguat Attenuates Sepsis-induced Cardiac Injury

    Author: Li, Wanqian; Zheng, Cheng; Zhang, Xijiang; Wang, Binhui; Shen, Enjian; Wang, Lingjun; Chen, Guang; Lin, Ronghai
    Journal: CURRENT MOLECULAR PHARMACOLOGY. 2025; Vol. 17, Issue , pp. -. DOI: 10.2174/0118761429387280250506114040        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386165.20
    NATURE REVIEWS MICROBIOLOGY250124.00
    NATURE REVIEWS GENETICS32074.80
    CELL70567.80
    NATURE BIOTECHNOLOGY39966.40
    iMeta043.70
    Cell Metabolism21954.10
    Molecular Plant8539.20
    CELL RESEARCH14324.30
    NATURE METHODS25740.00
    同分区等级的其他期刊名称 h-index CiteScore
    MMWR Surveillance Summaries093.20
    Journal of the National Cancer Center031.20
    Carbon Neutralization018.20
    Journal of Nanostructure in Chemistry027.90
    Journal of the National Comprehensive Cancer Network8819.40
    Journal of Advanced Research3621.70
    Soft Science014.30
    NEW ASTRONOMY REVIEWS5236.80
    Wiley Interdisciplinary Reviews-Data Mining and Knowledge Discovery3126.60
    ACS Measurement Science Au014.60
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分：
投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板，让您的学术沟通高效得体，显著提升论文发表效率！开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验：共12条

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）

    增值电信业务经营许可证：沪B2-20211595    网络文化经营许可证：沪网文[2023]2004-152号

    礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室